Disinformation wars: The digital mafia weaponising online news October 1, 2026 In part two of our investigation into the disinformation barons, Steve Dinneen dives into a world where hostile factions run smear campaigns for cash and victims have nowhere to hide. To catch up on the first part, follow this link “A fool may ask more questions in an hour than a wise man can answer in [...]
CENTRAL LONDON ALLIANCE BREAKS WORLD RECORDS™ TITLE FOR MOST PEOPLE PERFORMING CPR IN ONE HOUR September 30, 2026 London, 23 September 2026 – Central London Alliance has broken a new GUINNESS WORLD RECORDS™ for the most people performing CPR in one hour. The achievement, held at Tower Suites by Blue Orchid Hospitality property – the lead sponsors of the initiative – saw a marathon CPR session for 36 hours, culminating in a finale, [...]
Seventh Annual CreatorIQ Study Finds Creator Marketing Delivers Record ROI Amid Infrastructure and AI Complexities September 30, 2026 New data from CreatorIQ's seventh annual global State of Creator Marketing report shows nearly half of brands now earn 3x or greater ROI from creators, and budgets have increased 33% YoY, while AI-driven complexity and systems integration emerge as the industry's biggest challenges to operating at scale.
Manchester City hierarchy must also be punished if guilty, says former FA chief September 30, 2026 Manchester City chiefs must face personal punishments if the findings that they orchestrated almost £1bn of secret payments to the club are upheld, according to former Football Association boss Mark Palios. City say they intend to appeal the decision made by an independent commission that all but one of more than 100 charges brought by [...]
KBRA Releases DealCatalyst UK Mortgage Finance Conference Recap September 30, 2026 KBRA releases its recap of the DealCatalyst UK Mortgage Finance Conference held at The Landmark Hotel in London on 28 September. The report highlights key themes across housing affordability, refinancing, buy-to-let (BTL), specialist lending, and funding and liquidity management. Panellists described mortgage performance as resilient despite elevated borrowing costs and persistent housing supply constraints. Discussions [...]
Amentum Joint Venture Secures Preferred Position for Major UK Nuclear Contract September 30, 2026 United Kingdom nuclear site operator Sellafield Ltd has selected an Amentum (NYSE: AMTM) joint venture as preferred supplier for an asset care and asset creation program valued at up to $2.78 billion (£2.1 billion). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260930996796/en/ Under the Projects and Asset Care Execution (PACE) framework contract, [...]
rhode Launches at Sephora in Europe, Marking Its First Retail Presence Across 19 New Markets September 30, 2026 The launch brings rhode into physical retail across Europe, previously only being available for purchase in the region through rhodeskin.com
Klarvant Expands Namespace Command With Automation and Machine-to-Machine Access for AI Systems September 30, 2026 The British company named by the UK Government among partners expanding the Government Cyber Unit's Vulnerability Monitoring Service adds an automation layer, continuous CVE intelligence and an agent implementation in the Google Cloud marketplace
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026 September 30, 2026 Almirall’s scientific programme at EADV 2026 showcases advances in critical skin diseases, including atopic dermatitis, psoriasis and actinic keratosis, through more than 20 abstracts, including a late-breaking abstracts, alongside two expert-led symposia and an interactive industry AD hub session. New clinical data show consistent efficacy and effectiveness in atopic dermatitis treatment across body regions with lebrikizumab, including high-impact areas such as the face and neck1,2, while late-breaking ADlong results highlight sustained improvements in skin signs and itch with up to five years of treatment3. Final two-year data from the POSITIVE clinical study demonstrate the benefits on patient overall well-being and quality of life during tildrakizumab treatment4,5, and further data show evidence in patients with high disease burden and previous biologic treatment6,7. Almirall’s commitment to medical dermatology is reflected by its Gold Sponsorship of EADV 2026 and the launch of the ‘Face It’-campaign to raise awareness of the burden of atopic dermatitis with face and neck involvement, addressing the broader impact of skin diseases on patients.
Think EVs are dull? The Peugeot E-208 GTI will change your mind September 30, 2026 Tim Pitt drives the new electric Peugeot E-208 GTI hot hatch. Can it rekindle the spirit of the classic 205 GTI? Europe’s car companies are increasingly looking backwards to move forwards. Retro styling, which began as a bit of a gimmick with the Volkswagen New Beetle in 1998, is now melded into the mainstream. Take [...]